siRNA, Anti-METTL21A, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT56834WQ-2OMe)

The product SIRGT56834WQ-2OMe is a type of small interfering RNA (siRNA) that targets METTL21A gene and regulates the expression of gene. The siRNA interferes with the expression of METTL21A gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001127395.3
Alternative Names FAM119A; HCA557b; HSPA-KMT
Related Diseases Bardet-Biedl Syndrome 5
Purification HPLC
Target Gene
Gene ID 151194
Uniprot ID Q8WXB1
Sub Cat Target Species Modification Scale  
SIRGT57834WQ-2F METTL21A Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT58834WQ-2MOE METTL21A Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT59834WQ-LNA METTL21A Human Locked Nucleic Acid (LNA) Inquiry
SIRGT56834WQ-RB METTL21A Human Ribo-modified Inquiry
SIRGT57834WQ-BB METTL21A Human Backbone-modified Inquiry

Related Products